Loss-of-function mutations in the microglia-specific TREM2 strongly increase AD risk41,42 and loss of Trem2 in AD mouse models has a profound effect on microglial function and impairs their activation, migration to Aβ plaques and phagocytic activity43–47. This evidence concerns the gene TREM2 and Alzheimer disease.